A New U.S.-U.K. Trade Agreement Must Prioritize American INtellectual Property and INnovation


By Erik Paulsen

It looks increasingly unlikely that American and British negotiators will finalize a U.S.-UK trade agreement this year. When asked whether a deal could be struck by the end of 2020, one UK official recently responded, "Basically, no."

No one likes to wait. But if holding out for another year leads to a better deal, then that's certainly the right approach.

Our two countries have the potential to strike a top-notch agreement that sets the standard for future international trade pacts and puts the rest of the world on notice. Negotiators would be wise to use this extra time to secure state-of-the-art intellectual property and market access protections for American innovators.

The United States and the United Kingdom are two of the largest economies in the world and the lifeblood of the international trade ecosystem. In 2019, the United States traded nearly $6 trillion USD worth of goods and services with foreign nations, while the UK exchanged more than $1.8 trillion USD worth of the same wares. Given their dominance on the global economic stage, they can deliver the most ambitious bilateral trade deal in modern history.

The robust trade relationship between the United States and the United Kingdom certainly reinforces the prospect of that. In 2018, U.S. goods and services trade with the UK eclipsed $261 billion. America is the single largest investor in the UK. And fittingly, our British allies are also the largest investor in the United States.

Still, this relationship has room to grow -- especially when it comes to intellectual property protections.

Take the U.S. biopharmaceutical sector, which employs over four million Americans. Our innovation ecosystem produces more than half of the entire world's new medicines, helping people across the globe live longer and healthier lives.

But it's no simple feat. Bringing just one new drug through the development pipeline to patients typically costs billions of dollars and takes more than a decade. Even when biopharmaceutical companies commit to this investment, less than 12 percent of the medicines that enter clinical trials secure FDA approval.

The United Kingdom unfairly punishes U.S. drug companies with price controls on these expensive, cutting-edge medicines. This makes it even harder for American innovators to recoup R&D costs, which discourages them from future drug investments.

Especially now, in the new reality ushered in by the coronavirus, we cannot afford any disincentives against biomedical innovation. That's why U.S. trade negotiators must do all they can to ensure that the U.S.-UK trade deal prioritizes American scientists and medicine manufacturers.

The new U.S.-UK deal must also include 21st century protections for America's creative industries. Rampant online piracy in the United Kingdom robs American recording artists, producers, and film and television creators of hard-earned compensation. In 2018 alone, the United Kingdom saw nearly six billion visits to pirated websites. And just this spring -- during the coronavirus-induced quarantine -- traffic to pirated film sites increased by nearly 60 percent compared to visits earlier in the winter. A robust U.S.-UK trade deal must include provisions that address this blatant disregard for American innovation.

It's disappointing that the U.S. and UK officials have yet to reach a comprehensive trade agreement. But if we have to wait, let's use that time to hammer out the best deal possible -- one that serves as a gold standard for all future trade agreements.

Erik Paulsen represented Minnesota in the U.S. House of Representatives from 2009 to 2019. This piece originally ran in Newsweek.

More Resources


03/28/2024
The Democrats' Abundance Problem Revisited
Last week, I started revisiting my "Three Point Plan to Fix the Democrats and Their Coalition" from October of 2022. A brisk tour of the polling and political data suggested the Democrats are still in need of serious reform and that the three point plan is as relevant as ever. Here's the very short version of the plan:

more info


03/28/2024
Are Democrats Still Stuck With Biden?
Voters don't think much of the president but also remain wary of the obvious replacement.

more info


03/28/2024
What the Polls Say: RFK Jr. Hurting Biden, Helping Trump
In October, when Robert F. Kennedy Jr. abandoned his primary challenge to Joe Biden and instead launched an independent candidacy, the initial conventional wisdom was that he might hurt Donald Trump more than Biden.

more info


03/28/2024
The Twilight of the Republican 'McLeadership'
The Trump team is steadily purging the Republican leadership of holdovers from past decades. The departure of McCarthy, McDaniel, and McConnell is part of exorcising the legacy of a more important Mc whose influence is still felt in the U.S. Senate: John McCain.

more info


03/28/2024
The Funniest Media Story of the Year?
The following three things were obvious before MSNBC puked on itself in its public divorce with former RNC chief Ronna McDaniel, but aren't we glad the network didn't notice? More later, but briefly:

more info


03/28/2024
Abridging, Not Coercing, Is First Amendment's Yardstick
Under the First Amendment, the government may not abridge the freedom of speech, whether that abridging is done by coercing internet platforms or by getting them to cooperate in government efforts to censor the public.

more info


03/28/2024
Trade Cheaters Are Killing Aluminum Industry Jobs
Aluminum industry workers stand ready to do their part to move the nation forward. They just need the federal government to enforce trade laws.

more info


03/28/2024
It's Time for an Immigration Moratorium
An effective freeze on immigration could revitalize our national culture, politics, and economy before it's too late.

more info


03/28/2024
U.N. Gaza Resolution Could Lead to Lasting Cease-Fire
After 171 days of a relentless Israeli assault on Gaza, the United Nations Security Council approved a resolution calling for a cease-fire in Gaza, with the United States abstaining. It's a breakthrough that must be built upon.

more info


03/28/2024
Biden's War Against the Jews
Biden claims he is a lifelong friend of the Jewish people and a Zionist, but these empty words are cover for a decades-long antipathy

more info


03/28/2024
'Fairness Initiative' Tackles Too-High Government Pay
Governments at every level ought to cap public-sector wages and benefits at private-sector comparables.

more info


03/28/2024
My Friend Joe
I write now, in the worst pain and shock, with news of my friend Joe Lieberman's death just moments ago. I write because I know what his critics will be quick to write, what news reports have already re-circulated.

more info


03/28/2024
Why I'm Resigning From the Biden State Department
Since Hamas' attack on October 7, Israel has used American bombs in its war in Gaza, which has killed more than 32,000 people - 13,000 of them children - with countless others buried under the rubble, according to the Gaza Ministry of Health. Israel is credibly accused of starving the 2 million people who remain, according to the UN special rapporteur on the right to food; a group of charity leaders warns that without adequate aid, hundreds of thousands more will soon likely join the dead.

more info


03/28/2024
Gaza: Truths Behind All the Lies
From civilian casualties, the use of disproportionate force, and international biases, the mainstream narrative of the Gaza conflict often obfuscates the truth behind lies.

more info


03/28/2024
Obama, Fearing Biden Loss to Trump, Is On Phone To Strategize
As the election approaches, President Joe Biden is making regular calls to former President Barack Obama to catch up on the race or to talk about family. But Obama is making calls of his own to Jeffrey Zients, the White House chief of staff, and to top aides at the Biden campaign to strategize and relay advice.

more info



Custom Search

More Politics Articles:

Related Articles

Get Ready for an American Energy Comeback


Judging from the headlines, America's energy sector could collapse at any moment. Scattered amidst coronavirus coverage are reports of plummeting energy stocks and commodities traders paying people to take barrels of oil off their hands.

Trump Administration Should Reject Foreign Prescription Drug Price Controls


In responding to the coronavirus pandemic, President Trump has rightly focused on the tremendous innovative capacity of American businesses -- first by waiving regulations that impose unnecessary burdens, next by providing incentives to get tough jobs such as vaccine development done as quickly as possible.

Clearing the Air on the EPA's Coronavirus Response


The Environmental Protection Agency (EPA) agency recently issued a memo waiving certain compliance requirements for energy firms in light of the COVID-19 outbreak. A group of House Democrats falsely claimed the EPA's memo gives oil and gas companies an "open license to pollute." To address lawmakers' concerns, the EPA has tapped an internal watchdog to review the policy. But no matter how hard they look, the investigators won't find anything close to what Democrats have suggested.

If Trump is Not Reelected, America Will Be Hurting


Most every American has an opinion about the upcoming election. However, there are several realities we must face.

For Workers' Sake, Keep the Pressure on America's Trading Partners


In his marathon testimony before Congress earlier this summer, United States Trade Representative Robert Lighthizer detailed the trade-policy achievements of President Trump's first term. It's a list that should make the administration proud.

Superbugs will Kill Millions — Unless Congress Acts


We're in the midst of the worst health crisis of the 21st century -- and it's not COVID.

Why Do We Take to the Streets?


We Americans are quick to take our disagreements to the streets. In 2020, we have claimed many causes to do so. Millions came out to protest police violence and “resist” fascism. Others “rallied” against COVID-19 lockdowns and voter fraud. We may amass crowds to evoke sympathy or provoke debate. But demonstrations aggravate and intimidate, often drawing counter protesters if not ending in violence. And even when gatherings generate debate, we are tempted to settle them by who had the larger crowd size rather than the merits of the case.

Biden Administration Must Commit to a National Pandemic Preparedness Strategy


COVID-19 has killed more than 350,000 Americans. And with case counts and hospitalizations soaring, many more deaths are sadly in store.

The FDA Can Help Patients With Rare Diseases


When I was just 18 years old, I was diagnosed with hypoparathyroidism, a rare disease that causes seizures, extreme fatigue and other life-altering complications.

A Simple Fix for Biden to Help to Make Drugs More Affordable


Americans have problems affording many drugs at pharmacies and doctors' offices. About half of those who are sick have trouble paying for their medications, according to a recent poll from the Kaiser Family Foundation.

America is Ready For a Resurrection


The followers of Jesus believed in his resurrection because they saw him alive after he was dead. They had a powerful testimony of firsthand evidence seen with their own eyes.

Small Changes to 340B Can Make a Big Difference for Struggling Patients


The Covid-19 pandemic has made the issue of healthcare access more urgent than ever. Yet, at a time of deep divisions in Washington, chances for major reform are slim.

The Need for Reconciliation is a Sign of a Bad Bill


"Budget Reconciliation" may be the most popular phrase on Capitol Hill right now. This special legislative process allows certain bills to be passed in the Senate with a simple majority so long as they impact the budget.

America was Prepared to Fight Covid-19 Thanks to Intellectual Property Rights


When Covid-19 came ashore, glaring gaps in the government's pandemic preparedness became painfully obvious. Everything from inadequate stockpiles of personal protective equipment to confusing and uncoordinated guidance regarding closures hampered our early response.

Democrats Chose the Worst Time to Revive Medicare for All


Medicare for All just won't die. More than 100 House Democrats have signed onto new legislation that would outlaw all private insurance and put all Americans on a federally-run insurance plan within two years.